should we consider another booster dose of measles vaccine?

Should We Consider another Booster Dose of Measles Vaccine?

Background: To date, 36 years has passed since the beginning of measles vaccination; the disease is still circulating around the world, threatening lives of human beings especially in developing countries.  In recent years, we have confronted measles in previously vaccinated adults from all over the country. Objective: To find out if there is a need for changing our routine measles vaccination ...

Erythema nodosum :what should we consider about it?

Timing the second dose of measles vaccine.

After going through the latest issue of Indian Pediatrics, I was wondering whether a single recommendation can hold true to the vast and varied country like India? Do we know the age related magnitude of the problem? On one hand, in a metro like Delhi, where the coverage of the measles vaccination is so good that we hardly see any measals epidemics; there is a possibility that there may be some...

Immune Response of Hepatitis B Vaccine Booster Dose

One hundred and twenty-three children who had received no, incomplete and complete primary hepatitis B vaccination but had negative or very low anti-HBs titer were immunized with a single dose of recombinant hepatitis B vaccine. Blood tests for anti-HBs were obtained at 30 ± 5 days after the booster immunization. Twelve of 18 (66.7%) children without prior immunization (group 1) seroconverted f...

Hemophagocytic syndrome--should we consider it more often?

Hemophagocytic syndrome (HPS) is a rare condition characterized by overactive histiocytes, hepatosplenomegaly, fever and cytopenia, with two major types: familial, autosomal recessive genetic disease and acquired that can occur during systemic infections, immunodeficiency or malignancy. Inappropriate activation of macrophages by cytokines is the major mechanism of the disease. We report a case ...

Insulin pump therapy, should we consider it more often?

Erratic blood glucose control, hypoglycaemia unawareness and optimisation of glycaemic control during pregnancy are widely recognised indications for commencing diabetic patients on continuous subcutaneous insulin infusion (CSII) using an insulin pump. In patients without such a specific condition, the benefit of CSII over other forms of intensified treatment on glycaemic control and hypoglycae...